Skip to main content
. 2021 Feb 4;16:107. doi: 10.1186/s13018-021-02271-2

Table 5.

Comparison of the bisphosphonate and active vitamin D treatment

Variable Bisphosphonate group (n = 50) Denosumab group (n = 56) p value
Bisphosphonates
 Alendronate (35 mg), n (%) 16 (32) 22 (39.3) 0.43
 Risedronate (17.5 mg), n (%) 14 (28) 13 (23.2) 0.57
 Minodronate (50 mg), n (%) 20 (40) 21 (37.5) 0.79
Vitamin D
 Eldecalcitol (0.75 mg), n (%) 41 (82) 51 (91.1) 0.17
 Alphacalcidol, (1 mg), n (%) 9 (18) 5 (8.9) 0.17